TickerFacts.

Aldeyra Therapeutics, Inc. (ALDX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$30.33M
Year ended 2023-12-31
2014-12-31: -$4.79M2015-12-31: -$9.40M2016-12-31: -$15.16M2017-12-31: -$19.25M2018-12-31: -$30.12M2019-12-31: -$44.99M2021-12-31: -$42.56M2022-12-31: -$56.65M2023-12-31: -$30.33M-$30.33M
2014-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$30.33Mn/m2025-02-28, From 2023-01-01
2022-12-31-$56.65Mn/m2024-03-07, From 2022-01-01
2021-12-31-$42.56Mn/a2023-03-09, From 2021-01-01
No annual figure between 2019-12-31 and 2021-12-31.
2019-12-31-$44.99Mn/m2021-03-11, From 2019-01-01
2018-12-31-$30.12Mn/m2020-03-12, From 2018-01-01
2017-12-31-$19.25Mn/m2019-03-08, From 2017-01-01
2016-12-31-$15.16Mn/m2018-03-29, From 2016-01-02
2015-12-31-$9.40Mn/m2017-03-30, From 2015-01-01
2014-12-31-$4.79Mn/a2016-03-30, From 2014-01-01